Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article
Open Access

WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma

TETYANA DENYSENKO, LAURA ANNOVAZZI, PAOLA CASSONI, ANTONIO MELCARNE, MARTA MELLAI and DAVIDE SCHIFFER
Cancer Genomics & Proteomics January 2016, 13 (1) 31-45;
TETYANA DENYSENKO
1Research Center, Polyclinic of Monza Foundation, Vercelli, Italy
2Department of Neurosurgery, CTO Hospital/Health and Science City, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAURA ANNOVAZZI
1Research Center, Polyclinic of Monza Foundation, Vercelli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAOLA CASSONI
3Department of Medical Sciences, University of Turin/Health and Science City, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTONIO MELCARNE
2Department of Neurosurgery, CTO Hospital/Health and Science City, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTA MELLAI
1Research Center, Polyclinic of Monza Foundation, Vercelli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marta.mellai@cnbo.it
DAVIDE SCHIFFER
1Research Center, Polyclinic of Monza Foundation, Vercelli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Overview of the canonical Wingless-type MMTV integration site family (WNT)/β-catenin signaling. In the absence of WNT signal, β-catenin is captured by adenomatous polyposis coli (APC) and axin within a destruction complex, phosphorylated (P) by casein kinase Iα (CKIα) and glycogen synthase kinase-3β (GSK-3β) and targeted for ubiquitination (Ub) and proteasomal degradation. Transcription by transcription factor/lymphoid-enhancer-binding factor (TCF/LEF) is off due to the binding of repressors. A pool of β-catenin is engaged in the interactions with cadherins for cell–cell adhesion. The binding of WNT3a ligand to frizzled and low-density lipoprotein receptor-related proteins 5/6 (LRP5/6) co-receptors determines the inactivation of the destruction complex. This allows β-catenin to accumulate in the cytoplasm and translocate to the nucleus, where it forms a transcriptionally active complex with TCF/LEF family members.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Immunohistochemistry of Wingless-type MMTV integration site family (WNT)/β-catenin signaling pathway. A: Normal cortex. No WNT3a expression, ×200. B: Grade II oligodendroglioma. Moderate WNT3a expression on the cell membranes, ×400. C: Grade II astrocytoma. No WNT3a expression, ×400. D: Glioblastoma. Diffuse cytoplasmic and membranous WNT3a expression, ×400. E: Normal white matter. Slight membranous β-catenin expression, ×200. F: Grade II oligodendroglioma. Diffuse membranous β-catenin expression, ×400. G: Grade III astrocytoma. Moderate cytoplasmic and membranous β-catenin expression, ×400. H: Glioblastoma. High cytoplasmic and membranous β-catenin expression, ×400. I: Glioblastoma. Cytoplasmic and membranous β-catenin expression in proliferative endothelial cells, ×200. J: Glioblastoma. Nuclear and cytoplasmic β-catenin expression in hyperplastic endothelial cells, as indicated by arrows, ×630. K: Grade III astrocytoma. Granular expression of phospho-β-catenin, ×200. L: Glioblastoma. Phospho-β-catenin expression in the cytoplasm of proliferative endothelial cells, ×200. M: Glioblastoma. Positivity for phopsho-GSK-3β, ×200. All specimens stained with 3,3’ diaminobenzidine.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Wingless-type MMTV integration site family member 3a (WNT3a) and β-catenin immunohistochemical expression with respect to tumor type and histological malignancy grade.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Correlations among transcription factor 4 (TCF4), Ki-67/MIB-1 and cyclin D1 labeling indices (LIs). A: Glioblastoma. High nuclear TCF4 expression in several tumor cells, ×200. B: Grade II oligodendroglioma. TCF4 intensely positive nuclei, ×400. C: Glioblastoma. Several cyclin D1-positive nuclei in the same area as in (A), ×200. D: Several Ki-67/MIB-1-positive nuclei in the same area as in (A), ×200. E: Several Ki-67/MIB-1-positive nuclei in the same area as in (B), ×400. F: Glioblastoma. Nuclei of proliferative endothelial cells with high TCF4 expression, as indicated by arrows, ×400. All stained with 3,3’ diaminobenzidine.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Correlation among transcription factor 4 (TCF4), Ki-67/MIB-1 and cyclin D1 labeling indices (LIs). A: Linear regression analysis between TCF4 and Ki-67/MIB-1 LIs (r=0.761, p<0.0001). B: TCF4 and cyclin D1 LIs (r=0.739, p<0.0001). C: Cyclin D1 and KI-67/MIB-1 LIs (r=0.873, p<0.0001).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Immunofluorescence (IF) and immunocytochemistry (ICC) of glioblastoma stem cells. IF, Neurospheres: A: High cytoplasmic Wingless-type MMTV integration site family member 3a (WNT3a) expression. B: High cytoplasmic β-catenin expression. C: High nuclear transcription factor 4 (TCF4) expression. D: Cytoplasmic phopsho-glycogen synthase kinase-3β (GSK-3β) expression. IF, Adherent cells: E: Very poor cytoplasmic WNT3a expression. F: Negative β-catenin expression. G: Negative TCF4 expression. H: Positive phopsho-GSK-3β expression. IF, Adherent cells after 50 μM temozolomide treatment for 48 h: I: Positive cytoplasmic WNT3a expression. J: Positive cytoplasmic β-catenin expression. K: Nuclear and cytoplasmic TCF4 expression. L: Poor cytoplasmic phopsho-GSK-3β expression. Nuclei were counterstained with 4’,6-diamidino-2-phenylindole. All ×400 magnification. ICC, Neurospheres: M: Cytoplasmic WNT3a expression. N: Cytoplasmic and nuclear β-catenin expression. O: Nuclear TCF4 expression. ICC, Adherent cells: P: Prevailing nuclear TCF4 expression. All 3,3’ diaminobenzidine, ×400 magnification.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Western blot analysis. A: Representative analysis of two independent experiments displaying Wingless-type MMTV integration site family member 3a (WNT3a) and β-catenin expression in whole-cell extracts from glioblastoma cell lines, cultured as neurospheres or adherent cells. B: Quantitative analysis of WNT3a and β-catenin levels normalized to α-tubulin, showing higher amounts of the two proteins in neurospheres than adherent cells. C, D: β-Catenin expression by western blotting analysis in cytosolic and nuclear extracts from glioblastoma cell lines and tumor tissues.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    WNT3A expression levels by quantitative real-time polymerase chain reaction in gliomas and glioblastoma cell lines. A: Relative WNT3A expression levels in glioma tumor samples of different types and histological malignancy grades. B: Relative WNT3A expression levels in a panel of 24 glioblastoma cell lines, cultured as neurospheres (NS) or adherent cells (AC). Reported values are the average ± standard deviation (SD) of at least two independent experiments in triplicate.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Relationship of Wingless-type MMTV integration site family member 3a (WNT3a) and β-catenin expression with survival in glioma patients. Kaplan–Meier survival curves for overall survival (OS) with respect to WNT3a expression (A) and subcellular localization of β-catenin expression (B). M: membranous; C: cytoplasmic; N: nuclear.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Cancer Genomics & Proteomics
Vol. 13, Issue 1
January-February 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
TETYANA DENYSENKO, LAURA ANNOVAZZI, PAOLA CASSONI, ANTONIO MELCARNE, MARTA MELLAI, DAVIDE SCHIFFER
Cancer Genomics & Proteomics Jan 2016, 13 (1) 31-45;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
TETYANA DENYSENKO, LAURA ANNOVAZZI, PAOLA CASSONI, ANTONIO MELCARNE, MARTA MELLAI, DAVIDE SCHIFFER
Cancer Genomics & Proteomics Jan 2016, 13 (1) 31-45;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Proteogenomics of glioblastoma associates molecular patterns with survival
  • WNT vampirization by glioblastoma leads to tumor growth and neurodegeneration
  • Investigation of dacomitinib on reducing cell necrosis and enhancing cell apoptosis in C6 glioma rat model by MRI
  • Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma
  • Anticancer Activity of Artemisinin and its Derivatives
  • Google Scholar

Similar Articles

Keywords

  • Gliomas
  • glioblastoma multiforme
  • WNT3a
  • β-catenin
  • TCF4
  • prognosis
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire